Mesa Laboratories, Inc.
MLAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 2% | -4.2% | -1.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.5% | 54.6% | 61.8% | 63.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 17.6% | 25.5% | 16.9% | 9.7% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 4.1% | 8% | -11.4% | -2.7% |
| EPS Diluted | 0.45 | 0.85 | -1.31 | -0.31 |
| % Growth | -47.1% | 164.9% | -322.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |